Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised controlled trial of the use of topical application of tranexamic acid in primary cemented total hip replacement
ISRCTN ISRCTN58762744
ClinicalTrials.gov identifier
Public title A randomised controlled trial of the use of topical application of tranexamic acid in primary cemented total hip replacement
Scientific title
Acronym N/A
Serial number at source N0155164510
Study hypothesis Can we reduce blood loss associated with total hip replacement by using topical tranexamic acid?
Lay summary Not provided at time of registration
Ethics approval Added 14 October 2008: North West MREC Greater Manchester Strategic Health Authority, ref 05/MRE08/10, favourable ethical opinion on 11/04/2005, extended 02/02/2006
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal Diseases: Total hip replacement
Participants - inclusion criteria Patients having unilateral primary cemented total hip replacement.
Participants - exclusion criteria 1. Allergic to tranexamic acid
2. Pregnancy
3. History of DVT/pulmonary embolus
4. Patients involved in other trials
5. Known bleeding problems
6. Concurrent treatment with warfarin
7. Low dose molecular weight heparin or conventional heparin
8. Paget's disease or revision total hip replacement
Anticipated start date 01/06/2005
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 124
Interventions Randomised controlled trial
Primary outcome measure(s) Reduction in blood loss
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Pennine Acute Hospitals NHS Trust (UK), NHS R&D Support Funding
Trial website
Publications
Contact name Mr  Sattar  Alshryda
  Address Dept of Orthopaedics
Fairfield General Hospital
  City/town Bury
  Zip/Postcode BL9 7TD
  Country United Kingdom
  Tel +44 077950 78485
  Fax +44
  Email Sattar26@hotmail.com
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 28/09/2011
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central